Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer

2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer

US Patent 8791113 · Granted Jul 29, 2014

Estimated economic value: $123,958,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer2025
Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for t2025
Quinolin-2-one derivatives2024
Quinolin-2-one derivatives2021
Quinolin-2-one derivatives2021
Quinolin-2-one derivatives2020
1,4-dicarbonyl-piperidyl derivatives2020
Tricyclic heterocylic derivatives2020
Method of treating disorders using a pharmaceutical composition of oligopeptides2019
Compositions containing cyclic peptides and methods of use2019
3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives2019
3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives2019